Janku Filip Insider Trades

Insider Trading History

Track insider trading activity for Janku Filip. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.42M 60,612 shares
Last Trade
Jun 30, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$132k 5,407 shares
$24.50
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.55M 66,019 shares
Last Trade
Jun 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$131k 5,407 shares
$24.20
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.9M 81,093 shares
Last Trade
Jun 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$131k 5,407 shares
$24.20
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.54M 65,992 shares
Last Trade
Jun 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 6,000 shares
$23.90
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.4M 59,992 shares
Last Trade
Jun 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$138k 6,000 shares
$22.95
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.4M 60,000 shares
Last Trade
Jun 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 6,000 shares
$23.90
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.55M 66,000 shares
Last Trade
Jun 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$626k 30,000 shares
$20.85
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.4M 59,992 shares
Last Trade
Jun 24, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$643k 30,000 shares
$21.42
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $2.11M 89,992 shares
Last Trade
Jun 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$626k 30,000 shares
$20.85
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $2.25M 96,000 shares
Last Trade
Jun 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$124k 6,000 shares
$20.71
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.68M 71,837 shares
Last Trade
Jun 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$124k 6,000 shares
$20.71
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.4M 59,992 shares
Last Trade
Jun 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$240k 11,845 shares
$20.22
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.54M 65,837 shares
Last Trade
Feb 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$179k 9,189 shares
$19.50
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $1.76M 75,026 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$47.9k 3,155 shares
$15.17
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $3.25M 139,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.6M 170,000 shares
$15.31
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $3.77M 161,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 161,000 shares
$7.11
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $702k 30,000 shares
Last Trade
Sep 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$182k 30,000 shares
$6.08
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $2.83M 121,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$691k 121,000 shares
$5.71
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $3.16M 135,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 135,000 shares
$7.78
$23.41
Monte Rosa Therapeutics
Monte Rosa Therapeutics GLUE
Chief Medical Officer
Holding Value $843k 36,000 shares
Last Trade
Dec 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$341k 36,000 shares
$9.48
$23.41

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up